1
Krisbergh Harold M, Wachob David E, Augenbraun Joseph E, Lee Jae Hea Edward, Dill David A: Systeme dacces et procede assurant un acces interactif a une source dinformations par lintermediaire dun systeme de distribution de television, Access system and method for providing interactive access to an information source through a television distribution system. World Gate Communications, Sedna Patent Services, GOWLING LAFLEUR HENDERSON, October 16, 1997: CA2251085 (2 worldwide citation)

An interactive access system and method for accessing an information source through a television distribution system (11) is disclosed. The distribution system includes a television distribution network (12), headend distribution equipment (36), and a plurality of terminals. An input device and an u ...


2
DILL DAVID A: [fr] Formulation à libération prolongée pour réduire la fréquence de la miction et son procédé dutilisation, [de] Formulierung mit verlängerter Freisetzung zur Verringerung der Blasenentleerungshäufigkeit und Verwendungsverfahren dafür, [en] Extended-release formulation for reducing the frequency of urination and method of use thereof. WELLESLEY PHARMACEUTICALS, July 10, 2013: EP2612663-A1

[en] Compositions for reducing the frequency of urination are disclosed. One aspect of the present invention provides a pharmaceutical composition for reducing the frequency of urination, comprising: a first analgesic agent selected from the group consisting of aspirin, ibuprofen, naproxen sodium, i ...


3
DILL DAVID A: [fr] Formulation à libération retardée pour réduire la fréquence de la miction et son procédé dutilisation, [de] Formulierung mit verzögerter Freisetzung zur Verringerung der Blasenentleerungshäufigkeit und Verwendungsverfahren dafür, [en] Delayed-release formulation for reducing the frequency of urination and method of use thereof. WELLESLEY PHARMACEUTICALS, July 10, 2013: EP2612662-A1

[en] Compositions for reducing the frequency of urination are disclosed. One aspect provides a pharmaceutical composition for reducing the frequency of urination comprising a first analgesic agent, wherein said pharmaceutical composition is formulated in a delayed-release formulation and wherein sai ...


4
DILL DAVID A: [fr] Formule à libération retardée permettant de réduire la fréquence durination et procédé dutilisation associé, [de] Formulierung mit verzögerter Freisetzung zur Verringerung der Blasenentleerungshäufigkeit und Verwendungsverfahren dafür, [en] Delayed release formulation for reducing the frequency of urination and method of use thereof. WELLESLEY PHARMACEUTICALS, July 10, 2013: EP2612661-A1

[en] Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an analgesic agent formulated in a delayed-release formulation. Another method comprises ...


5
DILL DAVID A: [fr] Formule à libération étendue pour réduire la fréquence durination et son procédé dutilisation, [de] Formulierung mit verlängerter Freisetzung zur Verringerung der Blasenentleerungshäufigkeit und Verwendungsverfahren dafür, [en] Extended-release formulation for reducing the frequency of urination and method of use thereof. WELLESLEY PHARMACEUTICALS, July 10, 2013: EP2612660-A1

[en] Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an analgesic agent formulated in an extended-release formulation. Another method compris ...


6
DILL David A: Compositions et méthodes pour linhibition des contractions musculaires, Compositions and methods for the inhibition of muscle contraction. DILL David A, WANG Ping M D, January 12, 2012: WO/2012/005745

Compositions and methods for the inhibition of muscle contraction are disclosed. In one aspect, the present application discloses pharmaceutical compositions comprising analgesic agents for the inhibition of muscle contraction. In another aspect, the application discloses methods for the prophylacti ...


7
DILL David A, VOLFSON Ilya A: [fr] FORMULATION À LIBÉRATION PROLONGÉE POUR RÉDUIRE LA FRÉQUENCE DE LA MICTION ET PROCÉDÉ DUTILISATION DE CELLE-CI, [en] EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF. WELLESLEY PHARMACEUTICALS, DILL David A, VOLFSON Ilya A, WANG Ping, September 26, 2013: WO/2013/142274

[en] A method for reducing the frequency of urination is disclosed. The method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising one or more analgesic agents and one or more a-b lockers. In one embodiment, the one or more analgesic ag ...


8
DILL David A: [fr] FORMULATION À LIBÉRATION PROLONGÉE POUR RÉDUIRE LA FRÉQUENCE DE MICTION ET SON PROCÉDÉ DUTILISATION, [en] EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF. WELLESLEY PHARMACEUTICAL, DILL David A, WANG Ping, July 11, 2013: WO/2013/103357

[en] Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an analgesic agent formulated in an extended-release formulation. Another method compris ...


9

10
DILL DAVID A: UTILISATION DE LACETAMINOPHENE EN VUE DE REDUIRE LA FREQUENCE DE LA MICTION, USE OF ACETAMINOPHEN FOR REDUCING THE FREQUENCY OF URINATION. WELLESLEY PHARMACEUTICALS, WELLESLEY PHARMACEUTICALS, GOWLING WLG, August 21, 2018: CA2856673

Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an analgesic agent formulated in a delayed-release formulation. Another method comprises admi ...